エピソード

  • Episode 3: Why deep-tech ventures can fail - and the framework that explains it

    Episode 3: Why deep-tech ventures can fail - and the framework that explains it
    2026/03/10
    In this episode, Marks & Clerk's Anis Naidu is joined by Dr. Uday Phadke and Sam Dods, co-founders of Triple Chasm. Drawing on research across 7,000 companies globally, Uday and Sam have built a rigorous, data-driven framework for understanding why so many technology ventures fail to make the journey from laboratory to commercial success - and what the successful ten per cent consistently do differently.
    続きを読む 一部表示
    30 分
  • Episode 2: What investors really look for — and the IP mistakes that can cost start-ups their chance

    Episode 2: What investors really look for — and the IP mistakes that can cost start-ups their chance
    2026/03/10
    In this episode, Marks & Clerk's Anis Naidu is joined by two of the North West's most experienced voices in early-stage investment and innovation: Dr. Andy Round, Senior Investment Director at Deepbridge Capital, and Andy Roberts, former Head of Innovation at Bruntwood SciTech. Between them, they bring decades of experience backing, advising and accelerating life science start-ups.
    続きを読む 一部表示
    25 分
  • Episode 1: From lab to market - the real story of commercialising university research

    Episode 1: From lab to market - the real story of commercialising university research
    2026/03/10
    In this episode, Marks & Clerk's Anis Naidu sits down with Professor Aline Miller, Associate Vice President for Enterprise at the University of Manchester and founder of Manchester BIOGEL, which raised over £4 million, built a global distribution network, and achieved a successful exit in 2023. Now developing her second venture, Molla Pharm, Aline offers a thoughtful reflection on a decade of commercialising university research, speaking with the clarity and candour that come from firsthand experience.
    続きを読む 一部表示
    32 分